Clinical Trial Update: Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing [Phase 4]

View source ↗

Summary

Phase 4 trial comparing morning versus evening dosing of preservative-free Tafluprost/Timolol fixed combination for open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Drugs mentioned

• Tafluprost/Timolol fixed combination (preservative-free) ( Tafluprost/Timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma, Open-Angle | Phase 4 | Status: COMPLETED